These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27984320)

  • 1. Low Accuracy of the HeartMate Risk Score for Predicting Mortality Using the INTERMACS Registry Data.
    Kanwar MK; Lohmueller LC; Kormos RL; Loghmanpour NA; Benza RL; Mentz RJ; Bailey SH; Murali S; Antaki JF
    ASAIO J; 2017; 63(3):251-256. PubMed ID: 27984320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HeartMate Risk Score Identifies Patients With Similar Mortality Risk Across All INTERMACS Profiles in a Large Multicenter Analysis.
    Adamo L; Tang Y; Nassif ME; Novak E; Jones PG; LaRue S; Spertus JA; Mann DL
    JACC Heart Fail; 2016 Dec; 4(12):950-958. PubMed ID: 27614939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: application of the HeartMate II risk score.
    Thomas SS; Nahumi N; Han J; Lippel M; Colombo P; Yuzefpolskaya M; Takayama H; Naka Y; Uriel N; Jorde UP
    J Heart Lung Transplant; 2014 Jul; 33(7):675-81. PubMed ID: 24726424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HeartMate II Risk Score: An Adjusted Score for Evaluation of All Continuous-Flow Left Ventricular Assist Devices.
    Cowger JA; Castle L; Aaronson KD; Slaughter MS; Moainie S; Walsh M; Salerno C
    ASAIO J; 2016; 62(3):281-5. PubMed ID: 26955002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Heartmate Risk Score predicts morbidity and mortality in unselected left ventricular assist device recipients and risk stratifies INTERMACS class 1 patients.
    Adamo L; Nassif M; Tibrewala A; Novak E; Vader J; Silvestry SC; Itoh A; Ewald GA; Mann DL; LaRue SJ
    JACC Heart Fail; 2015 Apr; 3(4):283-90. PubMed ID: 25770410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of Postoperative Risk Scores for Survival Prediction in Interagency Registry for Mechanically Assisted Circulatory Support Profile 1 Continuous-Flow Left Ventricular Assist Device Recipients.
    Critsinelis AC; Lamba HK; Nguyen MT; Conroy JR; Cheema FH; Civitello AB; Delgado RM; Nair AP; Oberton SB; Rosengart TK; Frazier OH; Morgan JA; Chatterjee S
    ASAIO J; 2020 May; 66(5):539-546. PubMed ID: 31335367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Value of EuroSCORE II in Patients Undergoing Left Ventricular Assist Device Therapy.
    Menon AK; Mechelinck M; Unterkofler J; Goetzenich A; Autschbach R; Tewarie L; Moza A
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):475-82. PubMed ID: 26501222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    J Heart Lung Transplant; 2019 Feb; 38(2):114-126. PubMed ID: 30691593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new Bayesian network-based risk stratification model for prediction of short-term and long-term LVAD mortality.
    Loghmanpour NA; Kanwar MK; Druzdzel MJ; Benza RL; Murali S; Antaki JF
    ASAIO J; 2015; 61(3):313-23. PubMed ID: 25710772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score.
    Cowger J; Sundareswaran K; Rogers JG; Park SJ; Pagani FD; Bhat G; Jaski B; Farrar DJ; Slaughter MS
    J Am Coll Cardiol; 2013 Jan; 61(3):313-21. PubMed ID: 23265328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients).
    Lanfear DE; Levy WC; Stehlik J; Estep JD; Rogers JG; Shah KB; Boyle AJ; Chuang J; Farrar DJ; Starling RC
    Circ Heart Fail; 2017 May; 10(5):. PubMed ID: 28465311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Combination of Tricuspid Annular Plane Systolic Excursion and HeartMate Risk Score Predicts Right Ventricular Failure After Left Ventricular Assist Device Implantation.
    Raymer DS; Moreno JD; Sintek MA; Nassif ME; Sparrow CT; Adamo L; Novak EL; LaRue SJ; Vader JM
    ASAIO J; 2019; 65(3):247-251. PubMed ID: 29734261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    Ann Thorac Surg; 2019 Feb; 107(2):341-353. PubMed ID: 30691584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bayesian Model to Predict Survival After Left Ventricular Assist Device Implantation.
    Kanwar MK; Lohmueller LC; Kormos RL; Teuteberg JJ; Rogers JG; Lindenfeld J; Bailey SH; McIlvennan CK; Benza R; Murali S; Antaki J
    JACC Heart Fail; 2018 Sep; 6(9):771-779. PubMed ID: 30098967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine Learning-Based Prediction of Myocardial Recovery in Patients With Left Ventricular Assist Device Support.
    Topkara VK; Elias P; Jain R; Sayer G; Burkhoff D; Uriel N
    Circ Heart Fail; 2022 Jan; 15(1):e008711. PubMed ID: 34949101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Assessment in Patients with a Left Ventricular Assist Device Across INTERMACS Profiles Using Bayesian Analysis.
    Kanwar MK; Lohmueller LC; Teuteberg J; Kormos RL; Rogers JG; Benza RL; Lindenfeld J; McIlvennan C; Bailey SH; Murali S; Antaki JF
    ASAIO J; 2019 Jul; 65(5):436-441. PubMed ID: 30688695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
    Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
    J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
    Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.